Brian Taylor Slingsby - Director, 10%+ Owner at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
MLYS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Brian Taylor Slingsby - trading volume in the past year for Mineralys Therapeutics, Inc.

Holdings reported by Brian Taylor Slingsby for Mineralys Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8.64M $113M $13.05 Jul 24, 2024 Indirect
Stock Option 22K May 22, 2024 Direct Common Stock

Transactions reported by Brian Taylor Slingsby for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.